Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation.
Saved in:
| Title: | Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation. |
|---|---|
| Authors: | Gopal K; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Karwi QG; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Tabatabaei Dakhili SA; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Wagg CS; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Zhang L; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Sun Q; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Saed CT; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Panidarapu S; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada., Perfetti R; Applied Therapeutics, New York, NY, USA., Ramasamy R; Diabetes Research Program, New York University Grossman Medical Center, New York, NY, USA., Ussher JR; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada., Lopaschuk GD; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada. gary.lopaschuk@ualberta.ca. |
| Source: | Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Mar 28; Vol. 22 (1), pp. 73. Date of Electronic Publication: 2023 Mar 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36978133 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gopal+K%22">Gopal K</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Karwi+QG%22">Karwi QG</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Tabatabaei+Dakhili+SA%22">Tabatabaei Dakhili SA</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Wagg+CS%22">Wagg CS</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Sun+Q%22">Sun Q</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Saed+CT%22">Saed CT</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Panidarapu+S%22">Panidarapu S</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Perfetti+R%22">Perfetti R</searchLink>; Applied Therapeutics, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ramasamy+R%22">Ramasamy R</searchLink>; Diabetes Research Program, New York University Grossman Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ussher+JR%22">Ussher JR</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Lopaschuk+GD%22">Lopaschuk GD</searchLink>; Cardiovascular Research Institute, University of Alberta, Edmonton, AB, Canada. gary.lopaschuk@ualberta.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101147637%22">Cardiovascular diabetology</searchLink> [Cardiovasc Diabetol] 2023 Mar 28; Vol. 22 (1), pp. 73. <i>Date of Electronic Publication: </i>2023 Mar 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147637 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1475-2840 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214752840%22">14752840 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Diabetol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36978133 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12933-023-01811-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 73 Titles: – TitleFull: Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gopal K – PersonEntity: Name: NameFull: Karwi QG – PersonEntity: Name: NameFull: Tabatabaei Dakhili SA – PersonEntity: Name: NameFull: Wagg CS – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Sun Q – PersonEntity: Name: NameFull: Saed CT – PersonEntity: Name: NameFull: Panidarapu S – PersonEntity: Name: NameFull: Perfetti R – PersonEntity: Name: NameFull: Ramasamy R – PersonEntity: Name: NameFull: Ussher JR – PersonEntity: Name: NameFull: Lopaschuk GD IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 03 Text: 2023 Mar 28 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1475-2840 Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: Cardiovascular diabetology Type: main |
| ResultId | 1 |